KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Sales: 2011-2025

Historic Return on Sales for Rigel Pharmaceuticals (RIGL) over the last 11 years, with Sep 2025 value amounting to 0.40%.

  • Rigel Pharmaceuticals' Return on Sales rose 38.00% to 0.40% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.40%, marking a year-over-year increase of 38.00%. This contributed to the annual value of 0.10% for FY2024, which is 31.00% up from last year.
  • Rigel Pharmaceuticals' Return on Sales amounted to 0.40% in Q3 2025, which was up 10.02% from 0.36% recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Return on Sales high stood at 0.40% for Q3 2025, and its period low was -1.00% during Q1 2022.
  • Over the past 3 years, Rigel Pharmaceuticals' median Return on Sales value was -0.11% (recorded in 2024), while the average stood at -0.02%.
  • In the last 5 years, Rigel Pharmaceuticals' Return on Sales slumped by 91bps in 2022 and then spiked by 74bps in 2023.
  • Rigel Pharmaceuticals' Return on Sales (Quarterly) stood at -0.12% in 2021, then crashed by 37bps to -0.49% in 2022, then grew by 27bps to -0.21% in 2023, then spiked by 31bps to 0.10% in 2024, then soared by 38bps to 0.40% in 2025.
  • Its Return on Sales stands at 0.40% for Q3 2025, versus 0.36% for Q2 2025 and 0.18% for Q1 2025.